Skip to main content
SpringerLink
Log in
Book cover

Extravasation of Cytotoxic Agents pp 181–187Cite as

Mitomycin C

  • Chapter

  • 93 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Original articles

  1. Rentschler R, Wilbur D: Pyridoxine: a potential local antidote for mitomycin-C extravasation. J Surg Oncol 37: 269–271, 1988.

    Article  PubMed  CAS  Google Scholar 

  2. Argenta LC, Manders EK: Mitomycin C extravasation injuries. Cancer 51: 1080–1082, 1983.

    Article  PubMed  CAS  Google Scholar 

  3. Bertelli G, Dini D, Forno G, et al: Dimethylsulphoxide and cooling after extravasation of antitumour agents. Lancet 341: 1098–1099, 1993.

    Article  PubMed  CAS  Google Scholar 

  4. Bertelli G, Gozza A, Forno GB, et al: Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13: 2851–2855, 1995.

    PubMed  CAS  Google Scholar 

  5. Tsavaris NB, Komitsopoulou P, Karagiaouris P, et al: Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemother Pharmacol 30: 330–333, 1992.

    Article  PubMed  CAS  Google Scholar 

  6. Tsavaris NB, Karagiaouris P, Tzannou I, et al: Conservative approach to the treatment of chemotherapy-induced extravasation. J Dermatol Surg On-col 16: 519–522, 1990.

    CAS  Google Scholar 

  7. Ludwig CU, Stoll HR, Obrist R, et al: Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and a-tocopherole. Eur J Cancer Clin Oncol 23: 327–329, 1987.

    Article  PubMed  CAS  Google Scholar 

  8. Khanna AK, Khanna A, Asthana AK, et al: Mitomycin C extravasation ulcers. J Surg Oncol 28: 108–110, 1985.

    Article  PubMed  CAS  Google Scholar 

  9. Bowers DG, Lynch JB: Adriamycin extravasation. Plast Reconstr Surg 61: 86–92, 1978.

    Article  PubMed  Google Scholar 

  10. Fuller B, Lind M, Bonomi P: Mitomycin C extravasation exacerbated by sunlight. Ann Intern Med 94: 542, 1981.

    Article  PubMed  CAS  Google Scholar 

  11. Moertel CG, Reitemeier RJ, Hahn RG: Mitomycin C therapy in advanced gastrointestinal cancer. JAMA 204: 111–114, 1968.

    Article  Google Scholar 

  12. Alberts DS, Dorr RT: Case report: topical DMSO for mitomycin-C-induced skin ulceration. Oncol Nurs Forum 18: 693–695, 1991.

    PubMed  CAS  Google Scholar 

  13. Aizawa H, Tagami H: Delayed tissue necrosis due to mitomycin C. Acta Derm Venereol 67: 364–366, 1987.

    PubMed  CAS  Google Scholar 

  14. Herrera D, Burnham N: DMSO and extravasation of mitomycin. Oncol Nurs Forum 16: 155, 1989.

    PubMed  CAS  Google Scholar 

  15. Wood HA, Ellerhorst-Ryan JM: Delayed adverse skin reactions associated with mitomycin-C administration. Oncol Nurs Forum 11: 14–18, 1984.

    PubMed  CAS  Google Scholar 

  16. Bartkowski-Dodds L, Reville B: Extensive tissue ulceration due to apparent sensitivity reactions to mitomycin. Cancer Treat Rep 69: 925–927, 1985.

    PubMed  CAS  Google Scholar 

Secondary literature

  1. Bertelli G: Prevention and management of extravasation of cytotoxic drugs. Drug Safety 12: 245–255, 1995.

    Article  PubMed  CAS  Google Scholar 

  2. Schneider G: Paravasate von Zytostatika. Diagnostik und Therapie. Aina S. Schneider Verlag, 6th edition: 1–17, 1999.

    Google Scholar 

  3. Krämer I: Onkologische Pharmazie. In: Jaehde U, Radziwill R, Mühlebach S, et al (eds) Lehrbuch der Klinischen Pharmazie. Wissenschaftliche Verlagsgesellschaft mbH, 1st edition: 268–269, 1998.

    Google Scholar 

  4. Ignoffo RJ, Friedman MA: Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev 7: 17–27, 1980.

    Article  PubMed  CAS  Google Scholar 

  5. Gain M, Melzer S, Meyer-Jürshof A, et al: Mitomycin: Behandlung von Paravasaten. In: Gain M, et al (eds) ADKA-Zytostatika-Handbuch. Verlag Heiner Biller, Vol 1, 2nd edition: 35, 1997.

    Google Scholar 

  6. Dorr RT: Pharmacologic management of vesicant chemotherapy extravasations. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 109–118, 1994.

    Google Scholar 

  7. Stanley A: Managing complications of chemotherapy. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 3rd edition: 105–124, 1997.

    Google Scholar 

  8. Mullin S, Beckwith MC, Tyler LS: Prevention and management of antineoplastic extravasation injury. Hosp Pharm 35: 57–76, 2000.

    Google Scholar 

  9. Schneider SM, Distelhorst CW: Chemotherapy-induced emergencies. Semin Oncol 16: 572–578, 1989.

    PubMed  CAS  Google Scholar 

  10. Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 4: 41–60, 1990.

    Article  PubMed  CAS  Google Scholar 

  11. Gain M, Melzer S, Meyer-Jürshof A, et al: Allgemeiner Teil: Behandlung von Paravasaten. In: Gain M, et al (eds) ADKA-Zytostatika-Handbuch. Verlag Heiner Biller, Vol 1, 2nd edition: A42–44, 1997.

    Google Scholar 

  12. Barth J: Paravasate und deren Behandlung. In: Barth J (ed) ZytostatikaHerstellung in der Apotheke. Deutscher Apotheker Verlag, chapter VI-3: 1–9, 2000.

    Google Scholar 

  13. Cox K, Stuart-Harris R, Abdini G, et al: The management of cytotoxicdrug extravasation: guidelines drawn up by a working party for the Clinical Oncological Society of Australia. Med J Aust 148: 185–189, 1988.

    PubMed  CAS  Google Scholar 

Further reading

  1. Averbuch SD, Boldt M, Gaudiano G, et al: Experimental chemotherapy-induced skin necrosis in swine. J Clin Invest 81: 142–148, 1988.

    Article  PubMed  CAS  Google Scholar 

  2. Dorr RT, Soble MJ, Liddil JD, et al: Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dim-ethyl sulfoxide. J Clin Oncol 4: 1399–1404, 1986.

    PubMed  CAS  Google Scholar 

  3. Hahn SM, Sullivan FJ, De Luca AM, et al: Protection of mitomycin C induced skin extravasation with the nitroxide, 3-carbamoyl-proxyl (3CP). Int J Oncol 10: 119–123, 1997.

    PubMed  CAS  Google Scholar 

  4. Ignoffo RJ, Tomlin W, Rubinstein E, et al: A model for skin toxicity of antineoplastic drugs: doxorubicin (DOX), mitomycin-C (MMC), and vincristine (VCR). Clin Res 29: 437A, 1981.

    Google Scholar 

  5. Johnston-Early A, Cohen MH: Mitomycin C-induced skin ulceration remote from infusion site. Cancer Treat Rep 65: 529, 1981.

    PubMed  CAS  Google Scholar 

  6. Loth TS, Eversmann WW: Treatment methods for extravasations of chemotherapeutic agents: a comparative study. J Hand Surg 11A: 388–396, 1986.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria

    Ines Mader MD

  2. SMZ Floridsdorf, Krankenhaus und Geriatriezentrum, Vienna, Austria

    Patrizia E. Fürst-Weger Mag. pharm

  3. Clinical Division of Oncology, Department of Medicine I, University Hospital, Vienna, Austria

    Robert M. Mader DSc

  4. Anstaltsapotheke, Landeskrankenhaus — Universitätskliniken Innsbruck, Austria

    Elisabeth I. Semenitz MD, Mag. pharm

  5. Kaiser-Franz-Josef Hospital, Vienna, Austria

    Robert Terkola PharmD (Head of Pharmacy)

  6. Apotheke LKH-Univ.-Klinikum Graz, Austria

    Sabine M. Wassertheurer Mag. pharm.

Authors
  1. Ines Mader MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrizia E. Fürst-Weger Mag. pharm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert M. Mader DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisabeth I. Semenitz MD, Mag. pharm
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert Terkola PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sabine M. Wassertheurer Mag. pharm.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Wien

About this chapter

Cite this chapter

Mader, I., Fürst-Weger, P.E., Mader, R.M., Semenitz, E.I., Terkola, R., Wassertheurer, S.M. (2003). Mitomycin C. In: Extravasation of Cytotoxic Agents. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3710-9_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3710-9_37

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-3712-3

  • Online ISBN: 978-3-7091-3710-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation